NREP
NEW REPRESENTATIVE AT IB RECEIVED
06/06/2025
Back to search
Official data from USPTO
SCENITH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SCENITH
ST13
US500000079324881Class
5, 9, 42
Filing
79324881
Registration
7051034
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
06/07/2025
Trademark type
Word
Nice classes
5, 9, 42
Filing date
07/09/2021
Registration date
05/16/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2023
Last transaction
06/07/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FR
Examiner
SIRIGNANO, EMMA
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Institut National de la Santé et de la Recherche Médicale (INSERM)
Representatives
Cathleen E. Stadecker Downs Rachlin Martin PLLC
Technical classification
Nice Classes
Class 5Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations; diagnostic reagents; all the aforesaid goods reserved for the study of cellular metabolic responsesparticularly in the context of research related to anti-cancer therapies
Class 9
Scientific research apparatus and instrumentsdiagnostic apparatus for profiling the global metabolic capacities and dependencies of cells for laboratory or research use; recorded software programs for analyzing scientific and medical research results; laboratory instrumentsmedical laboratory research instruments for profiling the global metabolic capacities and dependencies of cells; all the aforesaid goods reserved for the study of cellular metabolic responsesparticularly in the context of research related to anti-cancer therapies
Class 42
Scientific and technological servicesscientific researchanalysistesting in the field of cellular metabolic responsesmedical diagnostic toolsanti-cancer therapies; scientific laboratory services; software development and design; research and development of new products for third parties; medical research; all the aforesaid services reserved for the study of cellular metabolic responsesparticularly in the context of research related to anti-cancer therapies
Publications
History of USPTO decisions and trademark events.
38 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/20/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/03/2023
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
08/17/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
08/17/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/16/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/16/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/16/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/01/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/05/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/28/2023
PUBO
PUBLISHED FOR OPPOSITION
02/28/2023
GPNX
NOTIFICATION PROCESSED BY IB
02/27/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/08/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/26/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/25/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/25/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/25/2023
CRSN
CORRECTION SENT TO IB
08/15/2022
CRCR
CORRECTION CREATED FOR IB
08/10/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/02/2022
GNFR
FINAL REFUSAL E-MAILED
08/02/2022
CNFR
FINAL REFUSAL WRITTEN
08/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/01/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/30/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/30/2022
RFNT
REFUSAL PROCESSED BY IB
04/25/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/07/2022
RFRR
REFUSAL PROCESSED BY MPU
04/07/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/31/2022
CNRT
NON-FINAL ACTION WRITTEN
03/30/2022
DOCK
ASSIGNED TO EXAMINER
03/27/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/04/2021
Continuous trademark protection
Get notified about every new filing that threatens SCENITH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.